ARCHIVES

Palbocicilib Doubles PFS In Phase II Trial to 20.2 Months

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

Emory’s Winship Cancer Institute Wins NCI Cancer Center Designation

April 17, 2009

Professional Fundraiser Poses Eight Questions For SU2C 3.

September 19, 2008

Four Detroit Institutions Merge Cancer Clinical, Research Programs

July 15, 1994

In Brief: Cancer Prevention Fellowship Program Application Sought; Grant Funds Available

March 18, 1994

New Drug for Lymphoma Enters Phase II Trial

May 28, 2004

Stop Cancer Foundation’s Future In Question, May Not Deliver All Of Funds Promised to NCI

January 18, 1991